Author

Viola A Heinzelmann-Schwarz

University of BaselORCID 0000-0002-5613-8629Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Viola A Heinzelmann-Schwarz2 papers · University of Basel

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1

Frequent Co-Authors

Francis JacobiD· 2 shared Alfred ZippeliusiD· 1 shared André Fedier· 1 shared Andreas HolbroiD· 1 shared Andreas S. BuseriD· 1 shared Andreas ZinggiD· 1 shared Anne BertoliniiD· 1 shared Anton OseledchykiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Francis JacobORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer Immunology ResearchPeer-reviewedApr 16, 2025

Targeting cancer-associated glycosylation for adoptive T cell therapy of gastro-intestinal and gynecological cancers

Andreas Zingg, Reto Ritschard, Helen Thut…·Heinz Philipp Laubli

This study develops a fully human CAR-T cell therapy targeting the STn antigen, showing activity in preclinical models of gastro-intestinal and gynecological cancers.

10 citationstop 5%

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivMar 6, 2024

De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data

Arthur Dondi, Nico Borgsmüller, Pedro Ferreira…·Niko Beerenwinkel

LongSom detects somatic variants in LR scRNA-seq data without normal samples, revealing clonal heterogeneity in ovarian cancer.

1 citation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 24, 2024

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis

Ricardo Coelho, Brinton A. Seashore-Ludlow, Sarah Schütz…·Francis Jacob

This study shows SMAC mimetics overcome apoptotic resistance in ovarian cancer by targeting the MSLN-TNF alpha axis, enhancing cell death and synergizing with chemotherapy.

DOI 10.1101/2024.01.24.576987

𝕏 PostBluesky